Skip to main content
Clinical Trials/RBR-34dc8f4
RBR-34dc8f4
Not Yet Recruiting
Phase 2

Effect of physical training associated or not with Whole-Body Electromyostimulation in Functional, Vascular and Autonomic variables of elderly people survivors of COVID-19: controlled clinical trial and randomized

niversidade Federal de São Carlos0 sitesApril 3, 2024

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Post-Acute COVID-19 Syndrome
Sponsor
niversidade Federal de São Carlos
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2024
End Date
June 17, 2026
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de São Carlos

Eligibility Criteria

Inclusion Criteria

  • Elderly people of both sexes; aged over 60 years; positive diagnosis for COVID 19 according to the test at least 2 months before being included in the exercise protocol; classified with Post COVID 19 Functional Status Scale greater than 2; volunteers who tested positive for COVID 19 and were isolated at home; as per WHO guidance; elderly people who required hospitalization due to COVID 19 after 30 days of hospital discharge as previously recommended and who present post COVID 19 syndrome; patients with persistent symptoms of fatigue and dyspnea within 1 to 3 months after confirmed diagnosis of COVID 19

Exclusion Criteria

  • Volunteers with orthopedic or neurological impairments that prevent participation in a physical exercise program; myocardial infarction; within six months of the beginning of the study; implanted pacemaker or any metallic synthesis; history of heart disease; unstable angina; arterial hypertension controlled; uncontrolled or insulin dependent diabetes mellitus and participation in a regular physical exercise program at the beginning of the study; hospital admission less than 72 hours ago; volunteers will also be excluded if they present hypersensitivity to electrical stimulation; chronic obstructive pulmonary disease;heart failure; asthma; previous tuberculosis; bronchitis; lung cancer; a condition that may compromise the performance of functional tests, documented diabetic neuropathy; cognitive deficit; difficulty understanding or adherence to study procedures; declared users of illicit drugs; pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials